Barbara K Burton, MD is the Professor of Pediatrics (Genetics, Birth Defects, and Metabolism) at Northwestern University, Feinberg School of Medicine. She is primarily interested in the diagnosis and treatment of patients with inherited metabolic disorders and in clinical trials of new therapies for rare disorders. Dr. Burton has a particular interest and expertise in disorders diagnosed through newborn screening (phenylketonuria and others) and in lysosomal storage disorders (MPS disorders, Morquio syndrome, etc).

Barbara K Burton completed her MD from the Northwestern University Feinberg School of Medicine followed by residency in Pediatrics and fellowship in Genetics from the Northwestern University, McGaw Medical Center (Children’s Memorial Hospital). She is board certified in Medical Genetics, Clinical Biochemical Genetics, and General Pediatrics.

Representative Publications:

Evaluation of the Long-Term Treatment Effects of Intravenous Idursulfase in Patients With Mucopolysaccharidosis II (MPS II) Using Statistical Modeling: Data From the Hunter Outcome Survey (HOS)

Characterization of Disease-Specific Chondroitin Sulfate Non-reducing End Accumulation in Mucopolysaccharidosis IVA

Population-Based Newborn Screening for Mucopolysaccharidosis Type II in Illinois: The First Year Experience

Survival in Idursulfase-Treated and Untreated Patients With Mucopolysaccharidosis Type II: Data From the Hunter Outcome Survey (HOS)

Share

Discuss in Social Wall

Share to rareTeam

Bookmark